During the past decade, GHESKIO conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "GHESKIO" #1 collaborator was "Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic" with 6 trials as a collaborator, "Analysis Group, Inc." with 3 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 3 trials as a collaborator, "Weill Medical College of Cornell University" with 3 trials as a collaborator and "Florida International University" with 2 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "GHESKIO" are "HIV" (3 trials), "HIV/AIDS" (3 trials), "HIV Infection" (2 trials), "Antiretroviral Therapy" (1 trials) and "HIV-1-infection" (1 trials). Many other conditions were trialed in "GHESKIO" in a lesser frequency.

Most popular intervention types in "GHESKIO" are "Drug" (4 trials), "Behavioral" (2 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amlodipine 5mg" (1 trials), "B/F/TAF" (1 trials), "Bedaquiline" (1 trials), "Clofazimine" (1 trials) and "Cohort 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "GHESKIO" are 7 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "GHESKIO". 1 are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in GHESKIO, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in GHESKIO, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".